Hydrogen-rich saline protects retina against glutamate-induced excitotoxic injury in guinea pig.
Wei L, Ge L, Qin S, Shi Y, Du C, Du H, Liu L, Yu Y, Sun X · Experimental eye research · 2012
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
The publication “Hydrogen-rich saline protects retina against glutamate-induced excitotoxic injury in guinea pig.” is organized in H2HUBB under the research focus hydrogen-rich saline eye health study 2012 wei. The publication is cited as Wei L, Ge L, Qin S, Shi Y, Du C, Du H, Liu L, Yu Y, Sun X, Experimental eye research, 2012. This in vitro or cellular study examined Hydrogen-rich saline protects retina against glutamate-induced excitotoxic injury in guinea pig. The abstract describes Cell culture / in vitro model; hydrogen delivered as hydrogen-rich saline and injected or infused hydrogen. The abstract reports: This result likely occurs by inhibiting the activation of glial cells, decreasing the production of the iNOS and GRP78 and promoting glutamate clearance. This is an automated editorial draft based on the abstract and requires source review before publication.
Hydrogen-rich saline eye health study 2012 wei overview
We investigated the protective effects and mechanism of hydrogen-rich saline in a glutamate-induced retinal injury model. Animal research can identify biological effects and support future investigation, but it cannot by itself establish safety or effectiveness in humans.
Study design and hydrogen intervention
Publication type: Animal study. Evidence type: Preclinical animal evidence. Research model or population: Guinea pig model. Blinding: Unknown. Control status: Unknown.
Delivery method: Hydrogen-rich saline.
Reported findings and scientific interpretation
For this hydrogen-rich saline eye health study 2012 wei, the study record reports the following: The abstract reports: This result likely occurs by inhibiting the activation of glial cells, decreasing the production of the iNOS and GRP78 and promoting glutamate clearance.
These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.
How this research record was prepared
H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.
Limitations, safety, and original source
Limitations: Laboratory findings may not translate directly to living organisms or clinical outcomes.
Safety: The abstract did not provide detailed safety or adverse-event information.
This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.